Reversible Myocardial Injury Associated With SARS-CoV-2 in an Infant
- PMID: 33073245
- PMCID: PMC7550045
- DOI: 10.1016/j.jaccas.2020.09.031
Reversible Myocardial Injury Associated With SARS-CoV-2 in an Infant
Abstract
Coronavirus disease-2019 is caused by the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) and has been associated with myocardial dysfunction and heart failure in adult patients. We report a case of reversible myocardial injury and heart failure in an infant with SARS-CoV-2 infection. (Level of Difficulty: Intermediate.).
Keywords: COVID-19, coronavirus disease-2019; CRP, C-reactive protein; DOI, day of illness; ECG, electrocardiogram; LVEF, left ventricular ejection fraction; MR, mitral regurgitation; NT-proBNP, N-terminal pro-B natriuretic peptide; SARS-CoV-2, severe acute respiratory syndrome-coronavirus-2; TnT, Troponin T; coronavirus disease-2019; pediatrics; reversible myocardial injury.
© 2020 The Authors.
Conflict of interest statement
The authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Figures
References
-
- Dong Y., Mo X., Hu Y. Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China. Pediatrics. 2020;145:e20200702. - PubMed
-
- Hollander S.A., Addonizio L.J., Chin C. Abdominal complaints as a common first presentation of heart failure in adolescents with dilated cardiomyopathy. Am J Emerg Med. 2013;31:684–686. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
